We provide you with 20 years of free, institutional-grade data for NBIX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of NBIX. Explore the full financial landscape of NBIX stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$57,205,166
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Lippoldt Darin | Sale | -10,000 | $169.56 | $1,695,650 | 2026-06-30 |
| Lippoldt Darin | Derivatives Exercise | 10,000 | 2026-06-30 | ||
| SHERWIN STEPHEN A | Sale | -25,000 | $163.81 | $4,095,175 | 2026-06-09 |
| SHERWIN STEPHEN A | Derivatives Exercise | 25,000 | 2026-06-09 | ||
| Norwalk Leslie V | Sale | -1,250 | $168.06 | $210,072 | 2026-06-08 |
| Cooke Julie | Sale | -36,937 | $154.83 | $5,718,778 | 2026-06-04 |
| Cooke Julie | Derivatives Exercise | 24,965 | 2026-06-04 | ||
| Keswani Sanjay Chandru | Sale | -1,733 | $154.84 | $268,338 | 2026-06-04 |
| Keswani Sanjay Chandru | Derivatives Exercise | 3,212 | 2026-06-04 | ||
| Keswani Sanjay Chandru | RSU | 3,212 | 2026-06-04 | ||
| Onyia Jude | Sale | -11,000 | $160.25 | $1,762,710 | 2026-06-02 |
| Onyia Jude | Derivatives Exercise | 11,000 | 2026-06-02 | ||
| Delaet Ingrid | Sale | -2,261 | $156.71 | $354,321 | 2026-06-02 |
| Delaet Ingrid | Derivatives Exercise | 2,261 | 2026-06-02 | ||
| Onyia Jude | Sale | -11,000 | $155.53 | $1,710,865 | 2026-05-29 |
| Onyia Jude | Derivatives Exercise | 11,000 | 2026-05-29 | ||
| Boyer David W. | Sale | -3,888 | $156.64 | $609,023 | 2026-05-28 |
| SHERWIN STEPHEN A | Derivatives Exercise | 3,318 | 2026-05-21 | ||
| SHERWIN STEPHEN A | RSU | 3,318 | 2026-05-21 | ||
| Sharp Shalini | Derivatives Exercise | 1,659 | 2026-05-21 | ||
| Sharp Shalini | RSU | 1,659 | 2026-05-21 | ||
| RASTETTER WILLIAM H | Derivatives Exercise | 3,318 | 2026-05-21 | ||
| RASTETTER WILLIAM H | RSU | 3,318 | 2026-05-21 | ||
| POPS RICHARD F | Derivatives Exercise | 3,318 | 2026-05-21 | ||
| POPS RICHARD F | RSU | 3,318 | 2026-05-21 | ||
| POON CHRISTINE A | Derivatives Exercise | 3,318 | 2026-05-21 | ||
| POON CHRISTINE A | RSU | 3,318 | 2026-05-21 | ||
| Norwalk Leslie V | Derivatives Exercise | 1,659 | 2026-05-21 | ||
| Norwalk Leslie V | RSU | 1,659 | 2026-05-21 | ||
| MORROW GEORGE J | Derivatives Exercise | 3,318 | 2026-05-21 | ||
| MORROW GEORGE J | RSU | 3,318 | 2026-05-21 | ||
| Mercier Johanna | Derivatives Exercise | 3,318 | 2026-05-21 | ||
| Mercier Johanna | RSU | 3,318 | 2026-05-21 | ||
| LYONS GARY A | Derivatives Exercise | 1,659 | 2026-05-21 | ||
| LYONS GARY A | RSU | 1,659 | 2026-05-21 | ||
| GORMAN KEVIN CHARLES | Sale | -245,088 | $154.33 | $37,824,872 | 2026-05-21 |
| GORMAN KEVIN CHARLES | Derivatives Exercise | 205,088 | 2026-05-21 | ||
| POPS RICHARD F | Sale | -15,000 | $157.65 | $2,364,761 | 2026-05-18 |
| POPS RICHARD F | Derivatives Exercise | 15,000 | 2026-05-18 | ||
| Norwalk Leslie V | Sale | -3,810 | $155.01 | $590,601 | 2026-05-14 |
| Ratz Andrew | Initial | 2026-03-17 | |||
| ABERNETHY MATT | Grant, award...etc | 9,968 | 2026-02-17 | ||
| ABERNETHY MATT | Sale | -9,124 | $123.1 | $1,123,164 | 2026-02-17 |
| ABERNETHY MATT | Derivatives Exercise | 6,940 | 2026-02-17 | ||
| ABERNETHY MATT | RSU | 6,940 | 2026-02-17 | ||
| Boyer David W. | Grant, award...etc | 9,968 | 2026-02-17 | ||
| Boyer David W. | Sale | -8,052 | $123.1 | $991,201 | 2026-02-17 |
| Boyer David W. | Derivatives Exercise | 4,952 | 2026-02-17 | ||
| Boyer David W. | RSU | 4,952 | 2026-02-17 | ||
| Gano Kyle | Grant, award...etc | 9,968 | 2026-02-17 | ||
| Gano Kyle | Sale | -10,621 | $123.1 | $1,307,445 | 2026-02-17 |
| Gano Kyle | Derivatives Exercise | 9,714 | 2026-02-17 | ||
| Gano Kyle | RSU | 9,714 | 2026-02-17 | ||
| Onyia Jude | Grant, award...etc | 19,935 | 2026-02-17 | ||
| Onyia Jude | Sale | -15,099 | $123.1 | $1,858,687 | 2026-02-17 |
| Onyia Jude | Derivatives Exercise | 7,967 | 2026-02-17 | ||
| Onyia Jude | RSU | 7,967 | 2026-02-17 | ||
| BENEVICH ERIC | Grant, award...etc | 16,613 | 2026-02-17 | ||
| BENEVICH ERIC | Sale | -12,227 | $123.1 | $1,505,144 | 2026-02-17 |
| BENEVICH ERIC | Derivatives Exercise | 6,049 | 2026-02-17 | ||
| BENEVICH ERIC | RSU | 6,049 | 2026-02-17 | ||
| Cooke Julie | Grant, award...etc | 9,968 | 2026-02-17 | ||
| Cooke Julie | Sale | -7,698 | $123.1 | $947,624 | 2026-02-17 |
| Cooke Julie | Derivatives Exercise | 4,298 | 2026-02-17 | ||
| Cooke Julie | RSU | 4,298 | 2026-02-17 | ||
| Lippoldt Darin | Grant, award...etc | 9,968 | 2026-02-17 | ||
| Lippoldt Darin | Sale | -8,558 | $123.1 | $1,053,490 | 2026-02-17 |
| Lippoldt Darin | Derivatives Exercise | 5,892 | 2026-02-17 | ||
| Lippoldt Darin | RSU | 5,892 | 2026-02-17 | ||
| Delaet Ingrid | Grant, award...etc | 19,935 | 2026-02-17 | ||
| Delaet Ingrid | Sale | -13,126 | $123.1 | $1,615,811 | 2026-02-17 |
| Delaet Ingrid | Derivatives Exercise | 4,360 | 2026-02-17 | ||
| Delaet Ingrid | RSU | 4,360 | 2026-02-17 | ||
| GORMAN KEVIN CHARLES | Grant, award...etc | 63,724 | 2026-02-17 | ||
| GORMAN KEVIN CHARLES | Sale | -40,305 | $124.12 | $5,002,657 | 2026-02-17 |
| GORMAN KEVIN CHARLES | Derivatives Exercise | 10,981 | 2026-02-17 | ||
| GORMAN KEVIN CHARLES | RSU | 10,981 | 2026-02-17 | ||
| BENEVICH ERIC | Sale | -1,292 | $136.06 | $175,790 | 2026-02-03 |
| BENEVICH ERIC | Derivatives Exercise | 2,294 | 2026-02-03 | ||
| BENEVICH ERIC | RSU | 2,294 | 2026-02-03 | ||
| ABERNETHY MATT | Sale | -1,368 | $136.06 | $186,130 | 2026-02-03 |
| ABERNETHY MATT | Derivatives Exercise | 2,437 | 2026-02-03 | ||
| ABERNETHY MATT | RSU | 2,437 | 2026-02-03 | ||
| Cooke Julie | Sale | -997 | $136.06 | $135,652 | 2026-02-03 |
| Cooke Julie | Derivatives Exercise | 1,741 | 2026-02-03 | ||
| Cooke Julie | RSU | 1,741 | 2026-02-03 | ||
| Delaet Ingrid | Sale | -475 | $136.06 | $64,629 | 2026-02-03 |
| Delaet Ingrid | Derivatives Exercise | 801 | 2026-02-03 | ||
| Gano Kyle | Sale | -1,580 | $136.06 | $214,975 | 2026-02-03 |
| Gano Kyle | Derivatives Exercise | 2,927 | 2026-02-03 | ||
| Gano Kyle | RSU | 2,927 | 2026-02-03 | ||
| GORMAN KEVIN CHARLES | Sale | -2,845 | $136.06 | $387,091 | 2026-02-03 |
| GORMAN KEVIN CHARLES | Derivatives Exercise | 5,142 | 2026-02-03 | ||
| GORMAN KEVIN CHARLES | RSU | 5,142 | 2026-02-03 | ||
| Norwalk Leslie V | Sale | -6,190 | $152.23 | $942,296 | 2025-12-17 |
| Norwalk Leslie V | Derivatives Exercise | 10,000 | 2025-12-17 | ||
| Lippoldt Darin | Sale | -4,376 | $159.65 | $698,615 | 2025-12-10 |
| Lippoldt Darin | Derivatives Exercise | 4,376 | 2025-12-10 | ||
| LYONS GARY A | Sale | -15,000 | $152.61 | $2,289,083 | 2025-12-04 |
| LYONS GARY A | Derivatives Exercise | 15,000 | 2025-12-04 | ||
| BENEVICH ERIC | Sale | -5,970 | $151.74 | $905,881 | 2025-12-02 |
| BENEVICH ERIC | Derivatives Exercise | 5,970 | 2025-12-02 | ||
| Onyia Jude | Sale | -2,248 | $152.16 | $342,056 | 2025-12-02 |
| Onyia Jude | Derivatives Exercise | 4,426 | 2025-12-02 | ||
| Onyia Jude | RSU | 4,426 | 2025-12-02 | ||
| MORROW GEORGE J | Sale | -15,000 | $143.37 | $2,150,513 | 2025-11-26 |
| MORROW GEORGE J | Derivatives Exercise | 15,000 | 2025-11-26 | ||
| RASTETTER WILLIAM H | Sale | -18,000 | $151.82 | $2,732,690 | 2025-11-06 |
| RASTETTER WILLIAM H | Derivatives Exercise | 18,000 | 2025-11-06 | ||
| Gano Kyle | Sale | -300 | $141.97 | $42,591 | 2025-11-04 |
| Gano Kyle | Derivatives Exercise | 613 | 2025-11-04 | ||
| Gano Kyle | RSU | 613 | 2025-11-04 | ||
| GORMAN KEVIN CHARLES | Sale | -106,322 | $126.41 | $13,440,281 | 2025-08-11 |
| GORMAN KEVIN CHARLES | Derivatives Exercise | 106,322 | 2025-08-11 | ||
| Onyia Jude | Sale | -59,819 | $130.46 | $7,803,688 | 2025-07-11 |
| Onyia Jude | Derivatives Exercise | 59,819 | 2025-07-11 | ||
| Delaet Ingrid | Sale | -457 | $135 | $61,695 | 2025-07-11 |
| Delaet Ingrid | Derivatives Exercise | 457 | 2025-07-11 | ||
| Onyia Jude | Sale | -20,362 | $130.13 | $2,649,738 | 2025-07-07 |
| Onyia Jude | Derivatives Exercise | 20,362 | 2025-07-07 | ||
| GORMAN KEVIN CHARLES | Sale | -9,613 | $120.38 | $1,157,211 | 2025-05-29 |
| SHERWIN STEPHEN A | Derivatives Exercise | 2,869 | 2025-05-22 | ||
| SHERWIN STEPHEN A | RSU | 2,869 | 2025-05-22 | ||
| POPS RICHARD F | Derivatives Exercise | 2,869 | 2025-05-22 | ||
| POPS RICHARD F | RSU | 2,869 | 2025-05-22 | ||
| MORROW GEORGE J | Derivatives Exercise | 2,869 | 2025-05-22 | ||
| MORROW GEORGE J | RSU | 2,869 | 2025-05-22 | ||
| LYONS GARY A | Derivatives Exercise | 1,435 | 2025-05-22 | ||
| LYONS GARY A | RSU | 1,435 | 2025-05-22 | ||
| Norwalk Leslie V | Derivatives Exercise | 1,435 | 2025-05-22 | ||
| Norwalk Leslie V | RSU | 1,435 | 2025-05-22 | ||
| Mercier Johanna | Derivatives Exercise | 1,435 | 2025-05-22 | ||
| Mercier Johanna | RSU | 1,435 | 2025-05-22 | ||
| Sharp Shalini | Derivatives Exercise | 1,435 | 2025-05-22 | ||
| Sharp Shalini | RSU | 1,435 | 2025-05-22 | ||
| RASTETTER WILLIAM H | Derivatives Exercise | 2,869 | 2025-05-22 | ||
| RASTETTER WILLIAM H | RSU | 2,869 | 2025-05-22 | ||
| POON CHRISTINE A | Derivatives Exercise | 1,435 | 2025-05-22 | ||
| POON CHRISTINE A | RSU | 1,435 | 2025-05-22 | ||
| Cooke Julie | Derivatives Exercise | 6,468 | 2025-05-20 | ||
| RASTETTER WILLIAM H | Sale | -30,000 | $110.2 | $3,305,952 | 2025-05-07 |
| RASTETTER WILLIAM H | Derivatives Exercise | 30,000 | 2025-05-07 | ||
| Onyia Jude | Sale | -2,879 | $116.83 | $336,364 | 2025-02-14 |
| Onyia Jude | Derivatives Exercise | 5,407 | 2025-02-14 | ||
| Onyia Jude | RSU | 5,407 | 2025-02-14 | ||
| Gano Kyle | Sale | -2,558 | $116.84 | $298,889 | 2025-02-14 |
| Gano Kyle | Derivatives Exercise | 4,807 | 2025-02-14 | ||
| Gano Kyle | RSU | 4,807 | 2025-02-14 | ||
| Lippoldt Darin | Sale | -2,184 | $116.76 | $255,004 | 2025-02-14 |
| Lippoldt Darin | Derivatives Exercise | 4,100 | 2025-02-14 | ||
| Lippoldt Darin | RSU | 4,100 | 2025-02-14 | ||
| Delaet Ingrid | Sale | -1,471 | $116.69 | $171,650 | 2025-02-14 |
| Delaet Ingrid | Derivatives Exercise | 2,759 | 2025-02-14 | ||
| Delaet Ingrid | RSU | 2,759 | 2025-02-14 | ||
| Boyer David W. | Sale | -1,785 | $116.79 | $208,477 | 2025-02-14 |
| Boyer David W. | Derivatives Exercise | 3,352 | 2025-02-14 | ||
| Boyer David W. | RSU | 3,352 | 2025-02-14 | ||
| ABERNETHY MATT | Sale | -2,558 | $116.85 | $298,899 | 2025-02-14 |
| ABERNETHY MATT | Derivatives Exercise | 4,807 | 2025-02-14 | ||
| ABERNETHY MATT | RSU | 4,807 | 2025-02-14 | ||
| BENEVICH ERIC | Sale | -2,154 | $116.74 | $251,462 | 2025-02-14 |
| BENEVICH ERIC | Derivatives Exercise | 4,044 | 2025-02-14 | ||
| BENEVICH ERIC | RSU | 4,044 | 2025-02-14 | ||
| ROBERTS EIRY | Sale | -2,218 | $116.9 | $259,295 | 2025-02-14 |
| ROBERTS EIRY | Derivatives Exercise | 4,605 | 2025-02-14 | ||
| ROBERTS EIRY | RSU | 4,605 | 2025-02-14 | ||
| SHERWIN STEPHEN A | Sale | -13,831 | $116.69 | $1,613,923 | 2025-02-14 |
| GORMAN KEVIN CHARLES | Sale | -5,844 | $116.69 | $681,933 | 2025-02-14 |
| GORMAN KEVIN CHARLES | Derivatives Exercise | 10,979 | 2025-02-14 | ||
| GORMAN KEVIN CHARLES | RSU | 10,979 | 2025-02-14 | ||
| Cooke Julie | Sale | -1,551 | $116.77 | $181,105 | 2025-02-14 |
| Cooke Julie | Derivatives Exercise | 2,910 | 2025-02-14 | ||
| Cooke Julie | RSU | 2,910 | 2025-02-14 | ||
| ABERNETHY MATT | Sale | -980 | $118.27 | $115,909 | 2025-02-12 |
| ABERNETHY MATT | Derivatives Exercise | 1,860 | 2025-02-12 | ||
| ABERNETHY MATT | RSU | 1,860 | 2025-02-12 | ||
| Cooke Julie | Sale | -700 | $118.28 | $82,793 | 2025-02-12 |
| Cooke Julie | Derivatives Exercise | 1,329 | 2025-02-12 | ||
| Cooke Julie | RSU | 1,329 | 2025-02-12 | ||
| GORMAN KEVIN CHARLES | Sale | -2,274 | $118.37 | $269,167 | 2025-02-12 |
| GORMAN KEVIN CHARLES | Derivatives Exercise | 4,318 | 2025-02-12 | ||
| GORMAN KEVIN CHARLES | RSU | 4,318 | 2025-02-12 | ||
| ROBERTS EIRY | Sale | -980 | $118.22 | $115,853 | 2025-02-12 |
| ROBERTS EIRY | Derivatives Exercise | 1,860 | 2025-02-12 | ||
| ROBERTS EIRY | RSU | 1,860 | 2025-02-12 | ||
| Boyer David W. | Sale | -700 | $118.31 | $82,820 | 2025-02-12 |
| Boyer David W. | Derivatives Exercise | 1,329 | 2025-02-12 | ||
| Boyer David W. | RSU | 1,329 | 2025-02-12 | ||
| BENEVICH ERIC | Sale | -980 | $118.31 | $115,940 | 2025-02-12 |
| BENEVICH ERIC | Derivatives Exercise | 1,860 | 2025-02-12 | ||
| BENEVICH ERIC | RSU | 1,860 | 2025-02-12 | ||
| Lippoldt Darin | Sale | -911 | $118.25 | $107,727 | 2025-02-12 |
| Lippoldt Darin | Derivatives Exercise | 1,727 | 2025-02-12 | ||
| Lippoldt Darin | RSU | 1,727 | 2025-02-12 | ||
| Gano Kyle | Sale | -980 | $118.39 | $116,020 | 2025-02-12 |
| Gano Kyle | Derivatives Exercise | 1,860 | 2025-02-12 | ||
| Gano Kyle | RSU | 1,860 | 2025-02-12 | ||
| Lippoldt Darin | Sale | -1,250 | $152.91 | $191,133 | 2025-02-04 |
| Lippoldt Darin | Derivatives Exercise | 2,373 | 2025-02-04 | ||
| Lippoldt Darin | RSU | 2,373 | 2025-02-04 | ||
| Boyer David W. | Sale | -1,104 | $152.94 | $168,849 | 2025-02-04 |
| Boyer David W. | Derivatives Exercise | 2,096 | 2025-02-04 | ||
| ABERNETHY MATT | Sale | -1,283 | $152.87 | $196,136 | 2025-02-04 |
| ABERNETHY MATT | Derivatives Exercise | 2,436 | 2025-02-04 | ||
| ABERNETHY MATT | RSU | 2,436 | 2025-02-04 | ||
| BENEVICH ERIC | Sale | -1,207 | $152.94 | $184,599 | 2025-02-04 |
| BENEVICH ERIC | Derivatives Exercise | 2,294 | 2025-02-04 | ||
| BENEVICH ERIC | RSU | 2,294 | 2025-02-04 | ||
| Cooke Julie | Sale | -1,740 | $152.89 | $266,025 | 2025-02-04 |
| Cooke Julie | Derivatives Exercise | 1,740 | 2025-02-04 | ||
| Cooke Julie | RSU | 1,740 | 2025-02-04 | ||
| GORMAN KEVIN CHARLES | Sale | -2,707 | $152.92 | $413,967 | 2025-02-04 |
| GORMAN KEVIN CHARLES | Derivatives Exercise | 5,141 | 2025-02-04 | ||
| GORMAN KEVIN CHARLES | RSU | 5,141 | 2025-02-04 |
The information provided in this report about NBIX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Neurocrine Biosciences, Inc(NASDAQ:NBIX)Â

Neurocrine Biosciences, Inc., a biopharmaceutical company, discovers, develops, and markets pharmaceutical products for the treatment of neurological, endocrine, and psychiatric-based diseases and disorders in the United States. The company offers INGREZZA, a VMAT2 inhibitor for the treatment of tar...
Website: http://www.neurocrine.com
Founded: 1992
Full Time Employees: 825
Sector: Healthcare
Industry: Biotechnology
